Evidence map›Paper›PMID 42099013›Full record

ArticleBiophysical journal2026

Gating shift to an ohmic mode of TREK-1 channel induced by docosahexaenoic acid.

Emilie Bechard, Jean-Yves Le Guennec, Marie Demion

Abstract read
In one paragraph

Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emilie BechardPhyMedExp, INSERM U1046, CNRS UMR9412, University of Montpellier, Montpellier, France. Electronic address: etu.emilie.bechard@gmail.com.
Jean-Yves Le GuennecPhyMedExp, INSERM U1046, CNRS UMR9412, University of Montpellier, Montpellier, France.
Marie DemionPhyMedExp, INSERM U1046, CNRS UMR9412, University of Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TREK-1 channel is a polymodulated K2P channel that responds to a wide range of physical and chemical stimuli, enabling it to contribute to the regulation of cellular excitability. This member of the TREK sub-family exhibits an outward rectification resulting from voltage-dependent gating, which can be reversibly converted to an ohmic leak mode by both synthetic and natural modulators. The present study aimed to investigate the gating mechanism in response to docosahexaenoic acid (DHA), using transient transfections of either the wild-type (WT) TREK-1 channel or its G171D variant at the transmembrane (TM)2.6 position in HEK 293T cells. We reported that DHA enhances the WT TREK-1 current by increasing the proportion of channels in a conductive state across the entire membrane potential (Vm) range, effectively shifting TREK-1 into an ohmic mode. Furthermore, we observed that disrupting the C-type gate function blunted DHA-induced activation, suggesting that DHA acts by stabilizing the selectivity filter that may involve TM2. Additionally, we observed considerable variability in the initial activity of TREK-1 under control conditions, which accounts for the heterogeneous effects of DHA among cells. These findings highlight the complex gating mechanism of TREK-1 and reveal a dynamic mechanism by which DHA, and likely other polyunsaturated fatty acids (PUFAs), modulate Vm and influence cellular excitability.

Indexed as

Docosahexaenoic AcidsIon Channel GatingPotassium Channels, Tandem Pore DomainHEK293 CellsHumansMembrane PotentialsDocosahexaenoic Acidspotassium channel protein TREK-1Potassium Channels, Tandem Pore Domainchannel gatingohmic modepolyunsaturated fatty acidstatistical analysisstatistical modelTREK-1 channelvoltage dependence

Identifiers

PMID42099013
PMCPMC13507441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.